From the USA: Use of Transcatheter Aortic Valve Replacement Up in Adults Younger Than 60

For patients aged younger than 60 years, transcatheter aortic valve replacement (TAVR) is increasingly used and has overtaken surgical aortic valve replacement (SAVR), despite significantly better survival rates for SAVR, according to a study presented at the annual meeting of The Society of Thoracic Surgeons, held from Jan. 27 to 29 in San Antonio.

Joanna Chikwe, M.D., from the Smidt Heart Institute at Cedars-Sinai in Los Angeles, and colleagues examined clinical practice and midterm outcomes of TAVR and SAVR among patients aged younger than 60 years. Analyses included 2,360 patients who underwent TAVR and SAVR procedures (22.2 and 77.8 percent, respectively), with a median follow-up of 2.4 and 4.9 years, respectively.

Source: Advances and More licensed by HealthDay

https://advancesandmore.com/advances_article.htm?id=NzMxY2RiYmItZGU3OS00ZTBiLWIxOTctNzc2ZTU4ZmRjNmY0&client=Nw%3D%3D&section=undefined